(CIDRAP News) If an effective vaccine for pandemic H1N1 influenza is available, the federal government expects to mount an H1N1 vaccination campaign this fall, initially targeting schoolchildren, adults with health problems, pregnant women, and healthcare and emergency workers, a top US official said today.
(CIDRAP News) To outside observers, the novel H1N1 virus spreading quickly to every corner of the globe must seem like it came out of nowhere, but the organism is a fourth generation of the 1918 pandemic virus and comes from an H1N1 family tree that is colorful and complex, according to two historical reviews that appear today in the New England Journal of Medicine (NEJM).
(CIDRAP News) –At an emergency hearing today of the Senate appropriations committee, Sen Tom Harkin, D-Iowa, said the Obama administration will ask for $1.5 billion to fight the swine influenza epidemic, as committee members sought to get a handle on the elements and cost estimates of the public health response.
(CIDRAP News) Swine influenza viruses have never been documented as the cause of a human influenza pandemic, but in 1976 they generated pandemic fears strong enough to trigger a nationwide vaccination campaign.
The reporting of swine flu cases in two California children this week stirred memories of the 1976 episode, which caused major embarrassment for public health authorities when the pandemic never materialized.
(CIDRAP News) A study of the blood of older people who survived the 1918 influenza pandemic reveals that antibodies to the strain have lasted a lifetime and can perhaps be engineered to protect future generations against similar strains.
(CIDRAP News) This in-depth article investigates the prospects for development of vaccines to head off the threat of an influenza pandemic posed by the H5N1 avian influenza virus. Its seven parts put advances in vaccine technology in perspective by illuminating the formidable barriers to producing an effective and widely usable vaccine in a short time frame.
Editor's note: This is the first in a seven-part series investigating the prospects for development of vaccines to head off the threat of an influenza pandemic posed by the H5N1 avian influenza virus. The series puts advances in vaccine technology in perspective by illuminating the formidable barriers to producing an effective and widely usable vaccine in a short time frame.